Key result
Carvedilol within 24 hours is linked to ~72% lower mortality vs later initiation in post-PCI AMI.
Why the study?
The optimal timing for initiating oral beta-blockers after acute MI remains unclear in the context of current primary PCI practice.
Does early initiation of oral carvedilol (within 24 hours) reduce all-cause mortality in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention?
Cohort (n=412)
No
Does early initiation of oral carvedilol (within 24 hours) reduce all-cause mortality in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention?
Effect estimate: HR 0.28 (95% CI 0.06-0.89)
Absolute Event Rate: 6.4% vs 25.5%
p-value: p=0.036
Early initiation of oral carvedilol within 24 hours of acute MI treated with primary PCI is associated with significantly reduced long-term and in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
May support early carvedilol after primary PCI in AMI; leaves open need for randomized confirmation.
Dai et al. (2024) conducted a cohort in Acute myocardial infarction undergoing primary percutaneous coronary intervention (n=412). Early oral carvedilol vs. Late oral carvedilol (initiation after 24 hours) was evaluated on All-cause mortality (HR 0.28, 95% CI 0.06-0.89, p=0.036). Initiation of oral carvedilol within the first 24 hours reduced all-cause mortality compared to later initiation (HR 0.28) in acute myocardial infarction patients who underwent primary PCI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: